Showing results (351-360 of 443) with videos related to
Sort By:
Pageof 45
The Journal of Pharmacology and Experimental Therapeutics|March 13, 2008
Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarctionA R Kompa, F See, D A Lewis, et al.Journal of Hospital Medicine|June 24, 2026
Safety steps: A framework for promoting safe trainee autonomy in clinical emergenciesKathryn Grace Kompa, Janet Monroe, Virginia Brady, et al.The Journal of Physical Chemistry. A|April 28, 2010
Global sensitivity analysis for systems with independent and/or correlated inputsGenyuan Li, Herschel Rabitz, Paul E Yelvington, et al.BMC Genomics|June 6, 2014
Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaquesMaura Barbisin, Silvia Vanni, Ann-Christin Schmädicke, et al.International Journal of Cardiology|April 28, 2009
Effect of atorvastatin on cardiac remodelling and mortality in rats following hyperglycemia and myocardial infarctionJennifer H Martin, Kim A Connelly, Andrew Boyle, et al.Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|June 25, 2015
Anaplastology in times of facial transplantation: Still a reasonable treatment option?Sabine Maria Toso, Kerstin Menzel, Yvonne Motzkus, et al.Nature Communications|November 16, 2019
Oxygen-catalysed sequential singlet fissionNikolaus Wollscheid, J Luis Pérez Lustres, Oskar Kefer, et al.Genomics|March 7, 2003
Distribution of new human beta-defensin genes clustered on chromosome 20 in functionally different segments of epididymisFrancisco Javier Rodríguez-Jiménez, Alexander Krause, Sandra Schulz, et al.Macromolecular Rapid Communications|December 3, 2014
Emission turn-on and solubility turn-off in conjugated polymers: one- and two-photon-induced removal of fluorescence-quenching solubilizing groupsKorwin M Schelkle, Steffy Becht, Shirin Faraji, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 5, 2008
Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trialWilliam Kemp, John Colman, Kenneth Thompson, et al.Pageof 45